Workflow
ZACKS
icon
搜索文档
Buy 3 Momentum Anomaly Stocks as Markets Fall in the Last Leg of 2025
ZACKS· 2025-12-18 23:56
Key Takeaways DDS, SANM and COMM were picked using a screen combining long-term gains and short-term price dips.Each stock has surged 49.1%-189.9% over the past year but fell 11.4%-15.6% in the past week.All three hold a Momentum Score of B and meet strict volume, price, and market cap criteria.The broader U.S. equity markets witnessed a downtrend over the past few days, exhibiting a four-day losing streak on concerns regarding the economic health and the increasing valuation of AI firms. Industry experts w ...
3 Cloud Computing Stocks That Investors Can Opt to Buy Before 2026
ZACKS· 2025-12-18 23:56
Key Takeaways AMZN's AWS leads the IaaS market with 200 cloud services and strong customer adoption worldwide.TEAM is gaining from enterprise demand for cloud collaboration tools and new AI feature rollouts.NET expands in cloud security with Zero Trust integrations, serving 10,000 global companies.Cloud computing is increasingly gaining market traction as it reduces the operating costs of maintaining on-site data centers and deploying IT experts to manage the infrastructure, making it a highly cost-effectiv ...
Can Higher-Dose Wegovy Help Novo Nordisk Regain Obesity Market Share?
ZACKS· 2025-12-18 23:56
Key Takeaways NVO is pursuing approval for Wegovy 7.2 mg to counter slowing sales amid rising GLP-1 competition.STEP UP showed Wegovy 7.2 mg delivered 20.7% average weight loss vs 17.5% with the 2.4 mg dose.NVO has filed for the approval of Wegovy 7.2 mg in the U.S. and EU, with decisions expected in 2026.Novo Nordisk (NVO) is a leading player in the obesity market, driven by its blockbuster GLP-1 therapy Wegovy (semaglutide). However, despite being a core growth driver, Wegovy’s sales momentum has slowed i ...
Will Strength in Biotechnology Unit Continue to Drive Danaher's Growth?
ZACKS· 2025-12-18 23:56
Key Takeaways Biotechnology segment at DHR posted 6.5% core revenue growth in Q3 2025 on sustained bioprocessing momentum.Strong consumables and mAbs demand drove bioprocessing orders higher for a ninth quarter at Danaher.Despite equipment demand headwinds, Danaher expects Biotechnology core revenues to rise about 5% in Q4 2025.Danaher Corporation (DHR) has been benefiting from strength in its Biotechnology segment. In the third quarter of 2025, the segment’s core revenues increased 6.5% on a year-over-year ...
Southwest Airlines Ties Up With Turkish Airlines for Global Connection
ZACKS· 2025-12-18 23:56
Key Takeaways LUV ties up with Turkish Airlines to launch one-ticket transatlantic connections starting early 2026. LUV gains access to Turkish Airlines' global network, boosting connectivity across the globe. Southwest Airlines adds redesigned cabins in January 2026 to support connections.Southwest Airlines (LUV) is strengthening its international strategy by partnering with Turkish Airlines to offer one-ticket transatlantic travel, beginning in early 2026. The agreement allows travelers to connect seamles ...
How Much Upside is Left in WisdomTree, Inc. (WT)? Wall Street Analysts Think 28.22%
ZACKS· 2025-12-18 23:56
WisdomTree, Inc. (WT) closed the last trading session at $11.8, gaining 7.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $15.13 indicates a 28.2% upside potential.The mean estimate comprises six short-term price targets with a standard deviation of $1.5. While the lowest estimate of $13.25 indicates a 12.3% increase from the current price level, the most optimistic analyst expe ...
Wall Street Analysts Believe Photronics (PLAB) Could Rally 31.16%: Here's is How to Trade
ZACKS· 2025-12-18 23:56
Shares of Photronics (PLAB) have gained 60.2% over the past four weeks to close the last trading session at $32.96, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $43.23 indicates a potential upside of 31.2%.The average comprises three short-term price targets ranging from a low of $42.00 to a high of $45.00, with a standard deviation of $1.57. While the lowest estimate indicat ...
Here's Why Repsol (REPYY) Is a Great 'Buy the Bottom' Stock Now
ZACKS· 2025-12-18 23:56
A downtrend has been apparent in Repsol SA (REPYY) lately. While the stock has lost 5.3% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its last trading session. This could mean that the bulls have been able to counteract the bears to help the stock find support.While the formation of a hammer pattern is a technical indication of nearing a bottom with potential exhaustion of selling pressure, rising optimism among Wall Street analysts about the future earnings ...
Wall Street Analysts Predict a 54.99% Upside in Allot Communications (ALLT): Here's What You Should Know
ZACKS· 2025-12-18 23:56
Allot Communications (ALLT) closed the last trading session at $8.71, gaining 2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $13.5 indicates a 55% upside potential.The mean estimate comprises three short-term price targets with a standard deviation of $1.32. While the lowest estimate of $12.50 indicates a 43.5% increase from the current price level, the most optimistic analyst ...
Does Figure Technology (FIGR) Have the Potential to Rally 31.7% as Wall Street Analysts Expect?
ZACKS· 2025-12-18 23:56
Shares of Figure Technology (FIGR) have gained 0.2% over the past four weeks to close the last trading session at $37.29, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $49.11 indicates a potential upside of 31.7%.The mean estimate comprises nine short-term price targets with a standard deviation of $6.17. While the lowest estimate of $40.00 indicates a 7.3% increase from the c ...